Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

St Charles Pharmaceuticals Inc
Profile last edited on: 4/11/2016      CAGE: 467R1      UEI:

Business Identifier: Small molecule development-stage CNS company focused on treatment of pain
Year Founded
1997
First Award
2000
Latest Award
2010
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

650 Poydras Street Suite 2830
New Orleans, LA 70130
   (504) 524-9600
   knarducy@pacbell.net
   N/A
Location: Multiple
Congr. District: 02
County: Orleans Parish

Public Profile

St Charles Pharmaceuticals is focused on novel therapeutics targeting pain, neuroprotection, and neuroinflammation. Licensed out of Louisiana State University, St Charles Pharmaceuticals is developing pharmaceutical therapies for pain (acute, neuropathic, post-surgical, and chronic), neuroinflammation, and neuroprotection

Extent of SBIR involvement

User Avatar
Phase I Awards
7
Phase II Awards
4
Conversion Rate
57.14%
Phase I Dollars
$720,381
Phase II Dollars
$3,264,210
Total Awarded
$3,984,591

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2010 2 NIH $1,240,090
Project Title: Pain Relieving Properties of Analgesic Metabolites
2007 1 NIH $111,893
Project Title: Development of Non-Narcotic Intravenous Analgesics
2007 2 NIH $889,157
Project Title: Development of SCP-1/opioid combinations for pain
2004 1 NIH $109,305
Project Title: Novel Analgesics for the Treatment of Bone Cancer Pain
2004 2 NIH $599,068
Project Title: Analgesics For Chronic Pain Treatment In The Elderly

Key People / Management

  Kenneth W Narducy -- President

  Anthony W (Tony) Fox -- Chief Medical Officer

  Leslie Molony -- Chief Executive Officer

  Anthony L Vaccarino

Company News

There are no news available.